Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2014
03/12/2014CN102085377B Immunogenic composition and methods
03/12/2014CN102065881B Stable amyloid BETA monomers and oligomers
03/12/2014CN101921310B Dengue virus (DENV) specific HLA-A2 (Human Leukocyte Antigen-A2) restrictive epitope peptide and application thereof
03/12/2014CN101884784B Bv8 nucleic acids and polypeptides with mitogenic activity
03/12/2014CN101827609B High affinity human antibodies to human nerve growth factor
03/12/2014CN101820912B Antibody formulations
03/12/2014CN101820899B Composition for treating lung cancer, particularly of non-small lung cancers (NSCLC)
03/12/2014CN101679966B Genetically recombinant antibody composition having enhanced effector activity
03/12/2014CN101679521B Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof
03/12/2014CN101460054B Mature dendritic cell compositions and methods for culturing same
03/12/2014CN101418044B Immunoglobulin variants and uses thereof
03/11/2014US8669349 BCR-complex-specific antibodies and methods of using same
03/11/2014US8669237 Biodegradable immunomodulatory formulations and methods for use thereof
03/11/2014US8669100 DNA expression constructs encoding the Leishmania infantum antigens thiol-specific antioxidant protein and kinetoplastid membrane protein
03/11/2014US8669047 Real-time detection of influenza virus
03/11/2014US8669046 Reagents and methods for detecting influenza virus proteins
03/11/2014US8668912 Mycoplasma gallisepticum formulation
03/11/2014US8668911 Streptococcus vaccine compositions and methods of using the same
03/11/2014US8668910 Antibodies that specifically bind to the EphA2 receptor
03/11/2014US8668909 Anti MIF antibodies
03/11/2014US8668908 Method for alleviating chemotherapy side effects using extract of Dioscorea sp
03/11/2014US8668904 Influenza composition
03/11/2014CA2827426A1 Closed-circuit device and methods for isolation, modification, and re-administration of specific constituents from a biological fluid source
03/11/2014CA2595276C Anti-interferon gamma antibodies and methods of use thereof
03/11/2014CA2567449C Antibodies and related molecules that bind to psca proteins
03/11/2014CA2566620C Vaccine against hpv16 and hpv18 and at least another hpv type slected from hpv 31, 45 or 52
03/11/2014CA2558829C Methods for treating viral infection using il-28 and il-29 cysteine mutants
03/11/2014CA2531684C Binding molecules against sars-coronavirus and uses thereof
03/11/2014CA2422429C A method of treating a malignancy in a subject and a pharmaceutical composition for use in same
03/11/2014CA2418899C Use of immunogens to treat or prevent malignant breast tumours, immune or vascular system disorders stemming from extra-cellular factors
03/11/2014CA2396428C Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
03/11/2014CA2375912C Immunotherapy of autoimmune disorders using antibodies which target b-cells
03/06/2014WO2014036562A2 Target peptides for immunotherapy and diagnostics
03/06/2014WO2014036520A1 Combination therapies comprising anti-erbb3 agents
03/06/2014WO2014036438A2 Live brucellosis vaccines comprising attenuated brucella mutants
03/06/2014WO2014036412A2 A method for treating melanoma using a herpes simplex virus and an immune checkpoint inhibitor
03/06/2014WO2014036393A1 A method to improve pharmacokinetics of drugs
03/06/2014WO2014036385A1 Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (igf-1)
03/06/2014WO2014036384A1 Use of il-20 antagonists for promoting bone fracture healing
03/06/2014WO2014036357A1 Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r)
03/06/2014WO2014036349A1 Expression of chimeric ksac protein and method of producing soluble proteins by high pressure
03/06/2014WO2014036345A2 Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins
03/06/2014WO2014036198A1 Compositions and methods for specific inhibition of leishmania receptor for activated c-kinase (lack)
03/06/2014WO2014036182A2 Diagnosis and treatment of autism spectrum disorder
03/06/2014WO2014036076A1 Anti-prolactin receptor antibody formulations
03/06/2014WO2014036071A1 Antibody and protein formulations
03/06/2014WO2014036014A2 Dominant negative transcription factor for antagonizing oncogenic transcription factors via multimerization
03/06/2014WO2014035989A1 Flagellin fusion proteins and methods of use
03/06/2014WO2014035798A1 Silk lyogels for sustained release of protein therapeutics and methods of making and uses
03/06/2014WO2014035474A1 Compositions and methods for treating cancer
03/06/2014WO2014034754A1 Psf1-derived peptide
03/06/2014WO2014034735A1 Dna vaccine containing vegf-specific epitope and/or angiopoietin-2-specific epitope
03/06/2014WO2014034127A1 Binding/neutralizing human monoclonal antibodies against botulinum neurotoxin type b
03/06/2014WO2014034046A1 Vaccine formulation against toxoplasma gondii infection
03/06/2014WO2014033346A1 System for transporting biologically active molecules, comprising a nanoparticle, a peptide and a biologically active molecule
03/06/2014WO2014033313A1 Protective anti-etec antibody
03/06/2014WO2014033304A2 Highly diverse combinatorial antibody libraries
03/06/2014WO2014033266A1 Anti-sr-bi antibodies for the inhibition of hepatitis c virus infection
03/06/2014WO2014033193A1 Stabilised proteins for immunising against staphylococcus aureus
03/06/2014WO2014033192A1 Stabilised proteins for immunising against staphylococcus aureus
03/06/2014WO2014033191A1 Stabilised proteins for immunising against staphylococcus aureus
03/06/2014WO2014033190A1 Stabilised proteins for immunising against staphylococcus aureus
03/06/2014WO2014033149A1 Marker vaccine
03/06/2014WO2014033130A1 Cluster of differentiation 36 (cd36) as a therapeutic target for hiv infection
03/06/2014WO2014033097A1 Tumor vaccination
03/06/2014WO2014033074A1 Blood brain barrier shuttle
03/06/2014WO2014032176A1 Methods for the treatment of hepatitis b and hepatitis d infections
03/06/2014WO2014026033A9 Cross-reactive t cell epitopes of hiv, siv, and fiv for vaccines in humans and cats
03/06/2014WO2014015287A3 Influenza vaccine consisting of a mva which expresses influenza antigens fused to vaccinia secretory signal sequences
03/06/2014WO2014011853A3 Igy from norovirus p particles and their derivatives
03/06/2014WO2013179044A3 Cladosporium peptides
03/06/2014WO2013177440A3 Ordered flagellin array as an immunostimulant
03/06/2014WO2013177055A3 ANTI-Ly6E ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE
03/06/2014WO2013158782A3 Methods and compositions for treating cardiac arrhythmias
03/06/2014WO2013106485A3 Ultralong complementarity determining regions and uses thereof
03/06/2014WO2012166158A8 Methods and compositions for the treatment of metabolic syndrome, obstructive respiratory disorders, cancer and related diseases
03/06/2014WO2012145238A3 Methods for reducing an adverse immune response to a foreign antigen in human using cd4-binding molecules
03/06/2014US20140068793 Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
03/06/2014US20140065207 Therapies for cancer using rlip76
03/06/2014US20140065195 Ureaplasma vaccine and antibody for prevention and treatment of human, animal and cell culture infection
03/06/2014US20140065189 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines
03/06/2014US20140065188 Enterohemorrhagic Escherichia Coli Vaccine
03/06/2014US20140065187 Hyperbaric Device and Methods for Producing Inactivated Vaccines and for Refolding/Solubilizing Recombinant Proteins
03/06/2014US20140065186 Immunostimulant for Animals, Feed Containing the Same, and Method for Producing the Same
03/06/2014US20140065185 Mucosal Immunization
03/06/2014US20140065184 HLA-G Isoform for use in the Treatment of a Disease Associated with Bone Resorption
03/06/2014US20140065183 Conjugates of acyl homoserine lactone and catalase a from pseudomonas aeruginosa
03/06/2014US20140065182 Yeast-based therapeutic for chronic hepatitis b infection
03/06/2014US20140065181 Genetically stable recombinant modified vaccinia ankara (rmva) vaccines and methods of preparation thereof
03/06/2014US20140065180 West nile virus vaccine, and method for production thereof
03/06/2014US20140065179 Adjuvant composition containing citrulline
03/06/2014US20140065178 Methods and Compositions for Pseudoinfectious Alphaviruses
03/06/2014US20140065174 Pharmaceutical composition for enhanching immunity, and extract of poria
03/06/2014US20140065169 Methods of Treating Acute Myeloid Leukemia by Blocking CD47
03/06/2014US20140065168 Anti-kit antibodies and uses thereof
03/06/2014US20140065164 Ip-10 antibody dosage escalation regimens
03/06/2014US20140065162 Compositions and Methods for Treating Brain Tumors
03/06/2014US20140065160 Combination therapy
03/06/2014US20140065159 Antibody and protein formulations
03/06/2014US20140065154 Tlr3 binding agents
1 ... 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 ... 1823